For foreign companies looking to sell regulated products in Brazil, regulatory compliance is not optional — it is a structural requirement to access the market.

Brazil has one of the most robust regulatory frameworks in Latin America, especially for products that may impact health, safety, or consumer well-being. These regulations are overseen by ANVISA (Agência Nacional de Vigilância Sanitária), Brazil’s national health regulatory authority.

Whether your company is a manufacturer, distributor, brand owner, exporter, or global supplier, understanding Brazil’s regulatory requirements is essential to operate successfully in the country.

Which Products Require ANVISA Authorization to Be Imported into Brazil

ANVISA regulates a wide range of products commonly imported into Brazil, including:

• Cosmetics and personal care products
• Pharmaceuticals and pharmaceutical ingredients
• Medical devices and hospital equipment
• Health-related chemicals and raw materials
• Food products, supplements, and ingredients
• Sanitizing and hygiene products

For these categories, compliance goes beyond customs documentation or freight operations. Both the products and the importing company must meet ANVISA regulatory requirements.

AFE Is Mandatory for Regulated Imports

In addition to product registration or notification, Brazilian regulation requires companies involved in importing, storing, or distributing ANVISA-regulated products to hold an AFE (Authorization of Operation).

The AFE is an official authorization issued by ANVISA that allows a company to legally operate with regulated products in Brazil.

It confirms that the company:

• Has an approved operational structure in Brazil
• Complies with sanitary, technical, and regulatory standards
• Is authorized to import, store, and distribute regulated products
• Is subject to ANVISA supervision and audits

Without an AFE, regulated imports cannot be legally completed in Brazil, regardless of the product’s quality standards or international certifications.

Why Working with a Certified Local Partner Matters

For foreign companies, navigating Brazil’s regulatory environment without a qualified local operator can create significant operational and regulatory risks, including:

• Shipment delays
• Customs holds and cargo retention
• Additional storage and compliance costs
• Import restrictions or rejected operations

This is why working with a Brazilian trading company already authorized by ANVISA is often the most efficient and secure way to access the market.

WM Trading holds the necessary ANVISA authorizations, including AFE, allowing the company to act as the importer of record for regulated products in Brazil.

How WM Trading Supports Regulated Imports into Brazil

By operating with an established regulatory and operational structure, WM Trading enables foreign companies to:

• Access the Brazilian market without opening a local entity
• Reduce regulatory and operational risks
• Ensure compliance with Brazilian sanitary legislation
• Structure imports with greater predictability and efficiency
• Accelerate the nationalization process for regulated products

By combining regulatory authorization, customs expertise, and operational execution, WM Trading acts as a strategic bridge between international suppliers and the Brazilian market.

Need support importing regulated products into Brazil?
Talk to WM Trading’s specialists and find out how to structure your operation with full ANVISA compliance.